Corcept Therapeutics (CORT) Non Operating Income (2016 - 2026)
Corcept Therapeutics (CORT) posted Non Operating Income of $4.6 million for Q2 2026, down 5.22% sequentially from $4.9 million in Q1 2026, and down 7.69% YoY from $5.0 million in Q2 2025.
Corcept Therapeutics (CORT) Non Operating Income (2016 - 2026) Analysis & Trends
Corcept Therapeutics has reported Non Operating Income for 11 years, with the latest figure at $4.6 million in Q2 2026.
- Quarterly Non Operating Income fell 7.69% year-over-year to $4.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $20.0 million (down 17.71% YoY) and the FY2025 annual result came in at $21.7 million, down 11.72% from the prior year.
- Non Operating Income fell to $4.6 million in Q2 2026 per CORT's latest filing, from $4.9 million in the prior quarter.
- Over five years, Non Operating Income peaked at $6.7 million in Q4 2024 and troughed at $80000.0 in Q1 2022.
- A 5-year average of $4.3 million and a median of $5.0 million in 2025 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income tumbled 70.91% in 2022, then jumped 4376.25% in 2023.
- Over 5 years, Non Operating Income stood at $1.8 million in 2022, then surged by 189.25% to $5.1 million in 2023, then soared by 30.31% to $6.7 million in 2024, then decreased by 19.04% to $5.4 million in 2025, then dropped by 14.6% to $4.6 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $4.6 million, $4.9 million, and $5.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 4.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.63 Mn |
| Mar 31, 2026 | 4.89 Mn |
| Dec 31, 2025 | 5.42 Mn |
| Sep 30, 2025 | 5.02 Mn |
| Jun 30, 2025 | 5.02 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Dec 31, 2024 | 6.70 Mn |
| Sep 30, 2024 | 6.35 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 5.49 Mn |
| Dec 31, 2023 | 5.14 Mn |
| Sep 30, 2023 | 5.21 Mn |
| Jun 30, 2023 | 3.35 Mn |
| Mar 31, 2023 | 3.58 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 630,000.00 |
| Mar 31, 2022 | 80,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Sep 30, 2021 | 72,000.00 |